Chieh-I Chen

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Ahmet Sezer, Mahmut Gümüş, Igor Bondarenko et al. · The Lancet · 2021 · 772 citations

Radiology, Medicine, Bronchial Neoplasm +9

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

Danny Rischin, Nikhil I. Khushalani, Chrysalyne D. Schmults et al. · Journal for ImmunoTherapy of Cancer · 2021 · 101 citations · Full text

Cancer Management, Median Time, Dermatology +16

Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy

Wenhui Wei, Keith Knapp, Li Wang et al. · Advances in Therapy · 2017 · 61 citations · Full text

Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs

Chieh-I Chen, Li Wang, Wenhui Wei et al. · Rheumatology Advances in Practice · 2018 · 59 citations · Full text

The Impact of OAB on Physical Activity in the United States: Results from OAB-POLL

Karin S. Coyne, Christopher Sexton, J. Quentin Clemens et al. · Urology · 2013 · 41 citations

Physical Activity Epidemiology, Physical Activity, Health Policy +8